The under-representation of KRAS mutants characterised RAG-0, but interestingly this group contained a high number of tumour suppressor mutants (KEAP1, RB1 and TP53) as well as CTNNB1 mutants, which could explain how the tumours initiated. The gene discussed is KRAS; the disease is neoplasm.